Dr. Pimple Popper’s SLMD Skincare Just Launched at Target

.DrPimplePopper's products are *good*.

As if you needed another reason for a Target run, there’s a new skincare line there you might want to take a second look at. Dr. Pimple Popper’s SLMD Skincare line is now available at the retail giant. So, if you’re a fan of dermatologist Dr. Sandra Lee , and her gross-but-amazing pimple-popping videos, now you can get a little of Dr. Lee at home. The seven-piece line is chock full of acne-busting ingredients such as salicylic and glycolic acid.

A few years ago, Dr. Lee launched SLMD Skincare, which made total sense considering her brand is all about pimples. But it’s not like she can make house calls to all of us who would die for her expertise. Instead, you can pick up one of her products or the entire acne system. Below, a quick breakdown of what you can shop at Target now.Salicylic Acid Cleanser Salicylic acid and allantoin work to exfoliate skin and unclog pores.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

StyleCaster /  🏆 104. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Dr. Pimple Popper Has a Skin-Care Line — and It’s Now Sold at TargetIt includes an affordable acne-fighting system.
Read more »

Dr. Pimple Popper Fans Have A Lot Of Theories About The Mystery Bump She Just Posted'It kind of looks like the bottom of a mushroom.'
Read more »

Watch Dr. Pimple Popper Remove a Huge Cyst Right Next to a Woman's EyeIn a two-minute Instagram clip, Dr. Sandra Lee goes to town on a woman's cystic temple zit.
Read more »

Watch Dr. Pimple Popper Pop a HUGE 6-Year-Old 'Unicorn Cyst' in the Middle of a Man's ForeheadWatch Dr. Pimple Popper Pop a HUGE 6-Year-Old 'Unicorn Cyst' In the Middle of a Man's Forehead
Read more »

Macquarie is both target and role model on payAussie watchdogs are cracking down on bank remuneration, and a group of shareholders plans to contest Macquarie’s pay at this year’s shareholder meeting. That’s odd, because Macquarie’s practices are pretty sensible – and its rewards pale versus poorer performers on Wall Street.
Read more »